[1] |
LI Shunle, LI Rong, TIAN Yaya, RAN Xiaoli, ZHAO Yanpei, XU Meng.
Association of serum KLF5 and actinin-4 levels with prognosis of TACE treatment for hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2024, 44(9): 1284-1289.
|
[2] |
AN Qi, QI Guangzhao, HAN Chao.
Aucubin inhibits the proliferation of human hepatocellular carcinoma cells line HepG2
[J]. Basic & Clinical Medicine, 2024, 44(3): 333-338.
|
[3] |
CHA Na, HAO Dandan, LI Tianzhu.
Research progress of microRNAs suppressing tumorigenesis through Hippo signaling
[J]. Basic & Clinical Medicine, 2023, 43(12): 1871-1875.
|
[4] |
YAN Wen, LI Nan, GU Tongnan, KONG Xiangzhao.
Screening and verification of key genes for colon cancer based on GEO database
[J]. Basic & Clinical Medicine, 2023, 43(11): 1685-1692.
|
[5] |
YANG Yaqian, PAN Yanfang, QU Mengyang, FANG Yan, YING Xiaoping, ZHANG Meiqian, WEI Jing.
Progress of research on the role of exosomes in the occurrence and development of liver precancerous lesions
[J]. Basic & Clinical Medicine, 2023, 43(9): 1453-1456.
|
[6] |
LIN Yingxue, CUI Haipeng, WANG Aiguo, YAO Yinhui, ZHAO Juan.
Rapamycin alleviates hepatocellular carcinoma progressing in transgenic mice
[J]. Basic & Clinical Medicine, 2023, 43(8): 1241-1246.
|
[7] |
DU Feng, CHEN Yiyang, ZHANG Nan, XU Junxuan, NING Tingting, ZHU Shengtao, ZHANG Shutian.
Expression and clinical significance of FOXL2NB in colorectal cancer
[J]. Basic & Clinical Medicine, 2023, 43(6): 909-915.
|
[8] |
HOU Mengjie, ZHAO Na, HUANG Fuqiang, WANG Yanan, LIU Fangming.
Apolipoprotein E negatively regulates Golgi membrane protein 73 to inhibit the proliferation of mouse liver cancer cell lines
[J]. Basic & Clinical Medicine, 2023, 43(5): 762-770.
|
[9] |
MI Yue, JIANG Qi-wei, SHEN Yan-jie, ZHANG De-yu, YE Qi-nong.
Construction and functional verification of AP-2 gene family eukaryotic expression vector
[J]. Basic & Clinical Medicine, 2022, 42(12): 1829-1834.
|
[10] |
WANG Yu-min, CHEN Ji-chao, WANG Hong-quan, WANG Jin-hua, TANG Bo.
Research progress of microRNAs as remodelers of lipid metabolic reprogramming in hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2022, 42(12): 1930-1934.
|
[11] |
XIE Si-an, CHEN Yi-yang, XU Jun-xuan, NING Ting-ting, ZHANG Nan, ZHU Sheng-tao, ZHANG Shu-tian.
Effect of PTOV1 expression on prognosis of colorectal cancer patients
[J]. Basic & Clinical Medicine, 2022, 42(8): 1176-1181.
|
[12] |
XIE Si-an, XU Jun-xuan, NING Ting-ting, ZHANG Nan, ZHU Sheng-tao, LIU Si.
VAV1 is a potential target and a new biomarker for the prognosis of atherosclerosis
[J]. Basic & Clinical Medicine, 2022, 42(7): 1092-1098.
|
[13] |
SUN Quan-peng, FAN Chao, ZHAN De-xi, FAN Yi-ming, SUN Wei-feng.
Ropivacaine inhibits proliferation, migration and invasion of human liver cancer cell line Hep3B
[J]. Basic & Clinical Medicine, 2022, 42(3): 448-453.
|
[14] |
HUANG Rong, ZHANG Jian, CHE Xu.
Effect of SLC4A10 expression on prognosis of patient with hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2022, 42(3): 461-466.
|
[15] |
MIAO Jia-wei, CHEN Jie, DENG Xue-song, XIONG Shu, LI Guo-li, MA Qiang.
Dehydrocostuslactone inhibits proliferation and promotes apoptosis of human hepatocellular carcinoma cell line HepG2
[J]. Basic & Clinical Medicine, 2020, 40(10): 1369-1373.
|